Polysialic Acid Neural Cell Adhesion Molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines
<p>Abstract</p> <p>Background</p> <p>Glioblastoma multiforme (GBM) is the most aggressive and frequent brain tumor, albeit without cure. Although patient survival is limited to one year on average, significant variability in outcome is observed. The assessment of biomar...
Main Authors: | Metellus Philippe, Loundou Anderson, Chinot Olivier, Coulibaly Béma, Amoureux Marie-Claude, Rougon Geneviève, Figarella-Branger Dominique |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-03-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/91 |
Similar Items
-
NCAM180 regulates Ric8A membrane localization and potentiates β-adrenergic response.
by: Marie-Claude Amoureux, et al.
Published: (2012-01-01) -
Generation and intracellular trafficking of a polysialic acid-carrying fragment of the neural cell adhesion molecule NCAM to the cell nucleus
by: Nina Westphal, et al.
Published: (2017-08-01) -
Distinctive PSA-NCAM and NCAM hallmarks in glutamate-induced dendritic atrophy and synaptic disassembly.
by: María Fernanda Podestá, et al.
Published: (2014-01-01) -
Exploring functional beta-cell heterogeneity in vivo using PSA-NCAM as a specific marker.
by: Melis Karaca, et al.
Published: (2009-01-01) -
Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2
by: Christelle Bouchart, et al.
Published: (2020-02-01)